Literature DB >> 16423833

Identification of a polymeric Ig receptor binding phage-displayed peptide that exploits epithelial transcytosis without dimeric IgA competition.

Ranveig Braathen1, Anders Sandvik, Gøril Berntzen, Sven Hammerschmidt, Burkhard Fleckenstein, Inger Sandlie, Per Brandtzaeg, Finn-Eirik Johansen, Vigdis Lauvrak.   

Abstract

The polymeric Ig receptor (pIgR), also called membrane secretory component (SC), mediates epithelial transcytosis of polymeric immunoglobulins (pIgs). J Chain-containing polymeric IgA (pIgA) and pentameric IgM bind pIgR at the basolateral epithelial surface. After transcytosis, the extracellular portion of the pIgR is cleaved at the apical side, either complexed with pIgs as bound SC or unoccupied as free SC. This transport pathway may be exploited to target bioactive molecules to the mucosal surface. To identify small peptide motifs with specific affinity to human pIgR, we used purified free SC and selection from randomized, cysteine-flanked 6- and 9-mer phage-display libraries. One of the selected phages, called C9A, displaying the peptide CVVWMGFQQVC, showed binding both to human free SC and SC complexed with pIgs. However, the pneumococcal surface protein SpsA (Streptococcus pneumoniae secretory IgA-binding protein), which binds human SC at a site distinct from the pIg binding site, competed with the C9A phage for binding to SC. The C9A phage showed greatly increased transport through polarized Madin-Darby canine kidney cells transfected with human pIgR. This transport was not affected by pIgA nor did it inhibit pIgR-mediated pIgA transcytosis. A free peptide of identical amino acid sequence as that displayed by the C9A phage inhibited phage interaction with SC. This implied that the C9A peptide sequence may be exploited for pIgR-mediated epithelial transport without interfering with secretory immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423833     DOI: 10.1074/jbc.M508509200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies.

Authors:  M Jack Borrok; Antonio DiGiandomenico; Nurten Beyaz; Gabriela M Marchetti; Arnita S Barnes; Kristen J Lekstrom; Sandrina S Phipps; Michael P McCarthy; Herren Wu; William F Dall'Acqua; Ping Tsui; Ruchi Gupta
Journal:  JCI Insight       Date:  2018-06-21

4.  Exploitation of the Polymeric Immunoglobulin Receptor for Antibody Targeting to Renal Cyst Lumens in Polycystic Kidney Disease.

Authors:  Erin E Olsan; Tamami Matsushita; Mina Rezaei; Thomas Weimbs
Journal:  J Biol Chem       Date:  2015-04-28       Impact factor: 5.157

5.  IgA-producing plasma cells originate from germinal centers that are induced by B-cell receptor engagement in humans.

Authors:  Francesca Barone; Anna Vossenkamper; Laurent Boursier; Wen Su; Alan Watson; Susan John; Deborah K Dunn-Walters; Paul Fields; Sonali Wijetilleka; Jonathan D Edgeworth; Jo Spencer
Journal:  Gastroenterology       Date:  2010-12-11       Impact factor: 22.682

6.  Enhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHH.

Authors:  Chris D Emmerson; Els J van der Vlist; Myrthe R Braam; Peter Vanlandschoot; Pascal Merchiers; Hans J W de Haard; C Theo Verrips; Paul M P van Bergen en Henegouwen; Edward Dolk
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

7.  Discovery and characterization of single-domain antibodies for polymeric Ig receptor-mediated mucosal delivery of biologics.

Authors:  Bharathikumar Vellalore Maruthachalam; Adam Zwolak; Xiefan Lin-Schmidt; Edward Keough; Ninkka Tamot; Sathya Venkataramani; Brian Geist; Sanjaya Singh; Rajkumar Ganesan
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.